Folgen
Christian Leporini
Christian Leporini
Dipartimento di Scienze della Salute, Università "Magna Graecia" di Catanzaro
Bestätigte E-Mail-Adresse bei unicz.it
Titel
Zitiert von
Zitiert von
Jahr
Adherence to therapy and adverse drug reactions: is there a link?
C Leporini, G De Sarro, E Russo
Expert opinion on drug safety 13 (sup1), 41-55, 2014
1652014
Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategy
M Ammendola, C Leporini, I Marech, CD Gadaleta, G Scognamillo, ...
BioMed research international 2014, 2014
1352014
Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two “challenging” case reports
C Palleria, C Leporini, S Chimirri, G Marrazzo, S Sacchetta, L Bruno, ...
Journal of Pharmacology and Pharmacotherapeutics 4 (1_suppl), S66-S72, 2013
1042013
Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis
F Ursini, C Leporini, F Bene, S D’Angelo, D Mauro, E Russo, G De Sarro, ...
Scientific Reports 7 (1), 5346, 2017
742017
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials
G Coppolino, C Leporini, L Rivoli, F Ursini, ED di Paola, V Cernaro, ...
Pharmacological research 129, 274-294, 2018
692018
Anti-vascular endothelial growth factor drugs safety and efficacy in ophthalmic diseases
P Ventrice, C Leporini, JF Aloe, E Greco, G Leuzzi, G Marrazzo, ...
Journal of Pharmacology and Pharmacotherapeutics 4 (1_suppl), S38-S42, 2013
662013
Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment
I Marech, C Leporini, M Ammendola, M Porcelli, CD Gadaleta, E Russo, ...
Cancer letters 380 (1), 216-226, 2016
582016
Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes
C Palleria, C Leporini, F Maida, E Succurro, G De Sarro, F Arturi, E Russo
Frontiers in neuroendocrinology 42, 76-92, 2016
552016
Tumour‐associated macrophages correlate with microvascular bed extension in colorectal cancer patients
I Marech, M Ammendola, R Sacco, G Sammarco, V Zuccala, N Zizzo, ...
Journal of cellular and molecular medicine 20 (7), 1373-1380, 2016
472016
Effect of pentoxifylline on renal outcomes in chronic kidney disease patients: a systematic review and meta-analysis
C Leporini, A Pisano, E Russo, G de Sarro, G Coppolino, D Bolignano
Pharmacological research 107, 315-332, 2016
452016
Pharmacovigilance and drug safety in Calabria (Italy): 2012 adverse events analysis
C Giofrè, F Scicchitano, C Palleria, C Mazzitello, M Ciriaco, L Gallelli, ...
Journal of Pharmacology and Pharmacotherapeutics 4 (1_suppl), S55-S60, 2013
422013
Targeting mast cells in gastric cancer with special reference to bone metastases
C Leporini, M Ammendola, I Marech, G Sammarco, R Sacco, ...
World journal of gastroenterology: WJG 21 (37), 10493, 2015
242015
C-Kit receptor and tryptase expressing mast cells correlate with angiogenesis in breast cancer patients
I Marech, M Ammendola, C Leporini, R Patruno, M Luposella, N Zizzo, ...
Oncotarget 9 (8), 7918, 2018
212018
A comprehensive safety evaluation of trabectedin and drug–drug interactions of trabectedin-based combinations
C Leporini, M Patane, F Saullo, P Rende, L Gallelli, ED Di Paola, ...
BioDrugs 28, 499-511, 2014
212014
Targeting endothelial progenitor cells in cancer as a novel biomarker and anti-angiogenic therapy
M Ammendola, C Leporini, M Luposella, R Sacco, G Sammarco, E Russo, ...
Current stem cell research & therapy 10 (2), 181-187, 2015
202015
Drug-drug interactions: antiretroviral drugs and recreational drugs
O Staltari, C Leporini, B Caroleo, E Russo, A Siniscalchi, G De Sarro, ...
Recent Patents on CNS Drug Discovery (Discontinued) 9 (3), 153-163, 2014
172014
Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review
C Leporini, F Saullo, G Filippelli, A Sorrentino, M Lucia, G Perri, ...
Journal of Pharmacology and Pharmacotherapeutics 4 (1_suppl), S78-S85, 2013
172013
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria …
C Palleria, L Iannone, C Leporini, R Citraro, A Manti, M Caminiti, ...
PLoS One 13 (10), e0205134, 2018
132018
Insulin-sensiting effects of tumor necrosis factor alpha inhibitors in rheumatoid arthritis: a systematic review and meta-analysis
C Leporini, E Russo, S D'Angelo, F Arturi, G Tripepi, R Peluso, ...
Reviews on Recent Clinical Trials 13 (3), 184-191, 2018
132018
Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European …
C Leporini, G Marrazzo, L Mumoli, S Esposito, L Gallelli, G Mangano, ...
Expert opinion on drug safety 16 (5), 515-522, 2017
122017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20